EC Number   |
Substrates   |
Products   |
Reversibility   |
|---|
 2.6.1.79 | oxaloacetate + L-glutamate |
- |
L-aspartate + 2-oxoglutarate |
- |
r |
 2.6.1.79 | oxaloacetate + L-glutamate |
78% of the activity with prephenate at 1.0 mM substrate concentration |
L-aspartate + 2-oxoglutarate |
- |
r |
 2.6.1.79 | prephenate + L-aspartate |
- |
L-arogenate + oxaloacetate |
- |
r |
 2.6.1.79 | prephenate + L-aspartate |
20% of the activity with L-glutamate |
L-arogenate + oxaloacetate |
- |
r |
 2.6.1.79 | prephenate + L-aspartate |
about 50% of the activity with L-glutamate |
L-arogenate + oxaloacetate |
- |
r |
 2.6.1.79 | prephenate + N-succinyl-L-2,6-diaminoheptanedioate |
- |
L-arogenate + N-succinyl-2-amino-6-oxoheptanedioate |
- |
? |
 2.6.1.79 | L-glutamate + prephenate |
- |
L-arogenate + 2-oxoglutarate |
- |
r |
 2.6.1.79 | prephenate + L-glutamate |
important step in biosynthesis of L-tyrosine and L-phenylalanine |
L-arogenate + 2-oxoglutarate |
- |
r |
 2.6.1.79 | prephenate + L-glutamate |
- |
L-arogenate + 2-oxoglutarate |
- |
r |
 2.6.1.79 | prephenate + L-glutamate |
optimal prephenate concentration is 0.5-1.0 mM |
L-arogenate + 2-oxoglutarate |
- |
r |